2
RESEARCH METHODOLOGY
34
5
MARKET OVERVIEW
Emerging economies drive growth in pelvic organ prolapse solutions with innovative technologies and investments.
55
5.2.1.1
Global prevalence of pelvic organ prolapse
5.2.1.2
Rise in female geriatric population
5.2.1.3
Improved awareness and early diagnosis
5.2.1.4
Advancements in robotic surgical techniques
5.2.2.1
Complications and recalls associated with transvaginal synthetic mesh
5.2.2.2
Limited access in emerging economies
5.2.2.3
Underdiagnosis due to social stigma
5.2.3.1
Increased investments in pelvic organ prolapse care from emerging economies
5.2.3.2
Rapid development of bioengineered and absorbable mesh
5.2.3.3
Advent of digital pelvic health solutions
5.2.4.1
Inconsistent clinical guidelines and treatment standards
5.2.4.2
High recurrence and reoperation rates
5.3
TRENDS AND DISRUPTIONS IMPACTING CUSTOMER BUSINESS
5.4.1
AVERAGE SELLING PRICE TREND, BY PRODUCT
5.4.2
AVERAGE SELLING PRICE TREND, BY TREATMENT AND KEY PLAYER
5.4.3
AVERAGE SELLING PRICE TREND, BY REGION
5.6
SUPPLY CHAIN ANALYSIS
5.8
INVESTMENT AND FUNDING SCENARIO
5.9.1.1
Pelvic mesh implants
5.9.1.2
Vaginal pessaries
5.9.2
COMPLEMENTARY TECHNOLOGIES
5.9.2.1
Wearable and app-based pelvic therapy devices
5.9.3
ADJACENT TECHNOLOGIES
5.9.3.1
Urinary incontinence devices
5.11.1
IMPORT SCENARIO (HS CODE 901890)
5.11.2
EXPORT SCENARIO (HS CODE 901890)
5.12
KEY CONFERENCES AND EVENTS, 2025–2026
5.13.1
NEGLECTED PESSARY IN PATIENT WITH PELVIC ORGAN PROLAPSE
5.13.2
SUCCESSFUL USE OF PESSARY FOR UTERINE PROLAPSE AFTER PELVIC TRAUMA IN YOUNG, NULLIPAROUS FEMALE
5.13.3
ROBOTIC AND LAPAROSCOPIC SACROCOLPOPEXY FOR PELVIC ORGAN PROLAPSE
5.14
REGULATORY LANDSCAPE
5.14.1
REGULATORY ANALYSIS
5.14.2
REGULATORY BODIES, GOVERNMENT AGENCIES, AND OTHER ORGANIZATIONS
5.15
PORTER’S FIVE FORCES ANALYSIS
5.15.1
BARGAINING POWER OF SUPPLIERS
5.15.2
BARGAINING POWER OF BUYERS
5.15.3
THREAT FROM NEW ENTRANTS
5.15.4
THREAT FROM SUBSTITUTES
5.15.5
INTENSITY OF COMPETITIVE RIVALRY
5.16
KEY STAKEHOLDERS AND BUYING CRITERIA
5.16.1
KEY STAKEHOLDERS IN BUYING PROCESS
5.17.2
POTENTIAL OF AI IN PELVIC ORGAN PROLAPSE/PELVIC FLOOR RECONSTRUCTION MARKET
5.17.3
KEY COMPANIES IMPLEMENTING AI
5.17.4
FUTURE OF AI IN PELVIC ORGAN PROLAPSE/PELVIC FLOOR RECONSTRUCTION MARKET
5.18.3
PRICE IMPACT ANALYSIS
5.18.4
IMPACT ON COUNTRY/REGION
5.18.5
IMPACT ON END-USE INDUSTRIES
6
PELVIC ORGAN PROLAPSE/PELVIC FLOOR RECONSTRUCTION MARKET, BY PRODUCT
Market Size & Growth Rate Forecast Analysis to 2030 in USD Million and Units | 46 Data Tables
90
6.2.1
ADOPTION OF ADVANCED, PATIENT-FOCUSED MESH TECHNOLOGIES
6.3.1
SHIFT TOWARD BIOCOMPATIBLE ALTERNATIVES
6.4.1
NEED FOR PRECISION IN PELVIC REPAIRS WITH ABSORBABLE AND ANTIBACTERIAL PRODUCTS
6.5.1
INTRODUCTION OF CUSTOM-FIT, HOME-USE PESSARY SOLUTIONS
6.6
PELVIC FLOOR THERAPY DEVICES
6.6.1
PATIENT PREFERENCE FOR MANAGING PELVIC FLOOR DISORDERS INDEPENDENTLY
6.7
ROBOTIC SURGERY SYSTEMS
6.7.1
ELEVATED DEMAND FOR MINIMALLY INVASIVE SOLUTIONS IN COMPLEX PELVIC REPAIRS
6.8
DIAGNOSTIC & ASSESSMENT TOOLS
6.8.1
ACCURATE DETECTION WITH ADVANCED IMAGING AND SMART DEVICES
7
PELVIC ORGAN PROLAPSE/PELVIC FLOOR RECONSTRUCTION MARKET, BY TREATMENT
Market Size & Growth Rate Forecast Analysis to 2030 in USD Million | 48 Data Tables
116
7.2.1.1
Large-scale adoption among older women
7.2.2.1
Increased preference for foundational repair techniques
7.2.3.1
Reduced postoperative discomfort and quicker recovery
7.2.4.1
Rise in demand for uterine-preserving options for prolapse repair
7.2.5
UTEROSACRAL OR SACROSPINOUS LIGAMENT FIXATION
7.2.5.1
Surge in native tissue repairs without mesh-based interventions
7.3.1
VAGINAL PESSARY MANAGEMENT
7.3.1.1
Emphasis on early intervention
7.3.2
PELVIC FLOOR MUSCLE THERAPY
7.3.2.1
Extensive use in early-stage prolapse and postpartum women
8
PELVIC ORGAN PROLAPSE/PELVIC FLOOR RECONSTRUCTION MARKET, BY APPLICATION
Market Size & Growth Rate Forecast Analysis to 2030 in USD Million | 26 Data Tables
145
8.2.1
WEAKENED PELVIC FLOOR MUSCLES PROMPT DEVELOPMENT
8.3.1
CHRONIC INCREASE IN INTRA-ABDOMINAL PRESSURE
8.4.1
SURGE IN APICAL VAGINAL SUPPORT DEFICIENCY
8.5.1
GROWTH IN PROLAPSE BURDEN
8.6.1
PREVALENCE OF RECTOVAGINAL SEPTUM DEFICIENCY
9
PELVIC ORGAN PROLAPSE/PELVIC FLOOR RECONSTRUCTION MARKET, BY END USER
Market Size & Growth Rate Forecast Analysis to 2030 in USD Million | 22 Data Tables
162
9.2.1
HIGH PATIENT INFLOW AND WIDESPREAD AVAILABILITY OF REIMBURSEMENTS
9.3.1
HEIGHTENED DEMAND FOR TAILORED, NON-INVASIVE, AND ACCESSIBLE CARE
9.4
AMBULATORY SURGERY CENTERS
9.4.1
COST ADVANTAGES AND FAVORABLE CLINICAL OUTCOMES
10
PELVIC ORGAN PROLAPSE/PELVIC FLOOR RECONSTRUCTION MARKET, BY REGION
Market Size & Growth Rate Forecast Analysis to 2030 in USD Million | 142 Data Tables
177
10.2.1
MACROECONOMIC OUTLOOK
10.2.2.1
Rise in female geriatric population to drive market
10.2.3.1
High symptom prevalence and demographic trends to drive market
10.3.1
MACROECONOMIC OUTLOOK
10.3.2.1
Advanced surgical innovations to drive market
10.3.3.1
Increased clinical focus on pelvic floor disorders and pelvic organ prolapse to drive market
10.3.4.1
Women's health policy initiatives to drive market
10.3.5.1
Demographic shifts to drive market
10.3.6.1
Rising popularity of non-surgical interventions to drive market
10.4.1
MACROECONOMIC OUTLOOK
10.4.2.1
Growing incidence of pelvic organ prolapse to drive market
10.4.3.1
Evolving healthcare delivery and infrastructure landscape to drive market
10.4.4.1
Booming medical tourism to drive market
10.4.5.1
Rapid growth of medical manufacturing companies to drive market
10.4.6.1
Surge in healthcare spending to drive market
10.4.7
REST OF ASIA PACIFIC
10.5.1
MACROECONOMIC OUTLOOK
10.5.2.1
Improving healthcare infrastructure to drive market
10.5.3.1
Expanding healthcare awareness and services to drive market
10.5.4
REST OF LATIN AMERICA
10.6
MIDDLE EAST & AFRICA
10.6.1
MACROECONOMIC OUTLOOK
11
COMPETITIVE LANDSCAPE
Discover top strategies and market dynamics shaping industry leaders and emerging players.
265
11.2
KEY PLAYER STRATEGIES/RIGHT TO WIN, 2022–2025
11.3
REVENUE ANALYSIS, 2022–2024
11.4
MARKET SHARE ANALYSIS, 2024
11.5
COMPANY EVALUATION MATRIX: KEY PLAYERS, 2024
11.5.5.1
Company footprint
11.5.5.2
Region footprint
11.5.5.3
Product footprint
11.5.5.4
Treatment footprint
11.5.5.5
Application footprint
11.6
COMPANY EVALUATION MATRIX: START-UPS/SMES, 2024
11.6.1
PROGRESSIVE COMPANIES
11.6.2
RESPONSIVE COMPANIES
11.6.5
COMPETITIVE BENCHMARKING
11.6.5.1
List of start-ups/SMEs
11.6.5.2
Competitive benchmarking of start-ups/SMEs
11.7
COMPANY VALUATION AND FINANCIAL METRICS
11.8
BRAND/PRODUCT COMPARISON
11.9
COMPETITIVE SCENARIO
11.9.1
PRODUCT LAUNCHES/APPROVALS
11.9.3
OTHER DEVELOPMENTS
12
COMPANY PROFILES
In-depth Company Profiles of Leading Market Players with detailed Business Overview, Product and Service Portfolio, Recent Developments, and Unique Analyst Perspective (MnM View)
284
12.1.1
BOSTON SCIENTIFIC CORPORATION
12.1.1.1
Business overview
12.1.1.2
Products offered
12.1.1.3
Recent developments
12.1.3
INTUITIVE SURGICAL OPERATIONS, INC.
12.1.7
INTEGRA LIFESCIENCES CORPORATION
12.2.2
MEDGYN PRODUCTS INC.
12.2.4
FEG TEXTILTECHNIK FORSCHUNGS- UND ENTWICKLUNGSGESELLSCHAFT MBH
12.2.5
BIOTEQUE AMERICA INC.
12.2.6
PERSONAL MEDICAL CORP.
12.2.11
MEDESIGN I.C. GMBH
12.2.12
DR. ARABIN GMBH & CO. KG
12.2.15
WILLOW INNOVATIONS, INC.
13.2
KNOWLEDGESTORE: MARKETSANDMARKETS’ SUBSCRIPTION PORTAL
13.3
CUSTOMIZATION OPTIONS
TABLE 1
POPULATION OF FEMALES AGED 50 AND ABOVE, 2024
TABLE 2
AVERAGE SELLING PRICING TREND OF PELVIC ORGAN PROLAPSE/PELVIC FLOOR RECONSTRUCTION PRODUCTS, BY TYPE, 2023–2025
TABLE 3
AVERAGE SELLING PRICE TREND OF PELVIC ORGAN PROLAPSE/PELVIC FLOOR RECONSTRUCTION PRODUCTS, BY TREATMENT AND KEY PLAYER, 2023–2025
TABLE 4
AVERAGE SELLING PRICE TREND OF PELVIC ORGAN PROLAPSE/PELVIC FLOOR RECONSTRUCTION PRODUCTS, BY REGION, 2023–2025
TABLE 5
ROLE OF COMPANIES IN ECOSYSTEM
TABLE 7
IMPORT DATA FOR HS CODE 901890-COMPLIANT PRODUCTS, BY COUNTRY, 2020–2024 (USD MILLION)
TABLE 8
EXPORT DATA FOR HS CODE 901890-COMPLIANT PRODUCTS, BY COUNTRY, 2020–2024 (USD MILLION)
TABLE 9
KEY CONFERENCES AND EVENTS, 2025–2026
TABLE 10
TIME, COST, AND COMPLEXITY OF REGISTRATION PROCESS IN JAPAN
TABLE 11
NORTH AMERICA: REGULATORY BODIES, GOVERNMENT AGENCIES, AND OTHER ORGANIZATIONS
TABLE 12
EUROPE: REGULATORY BODIES, GOVERNMENT AGENCIES, AND OTHER ORGANIZATIONS
TABLE 13
ASIA PACIFIC: REGULATORY BODIES, GOVERNMENT AGENCIES, AND OTHER ORGANIZATIONS
TABLE 14
LATIN AMERICA: REGULATORY BODIES, GOVERNMENT AGENCIES, AND OTHER ORGANIZATIONS
TABLE 15
REST OF THE WORLD: REGULATORY BODIES, GOVERNMENT AGENCIES, AND OTHER ORGANIZATIONS
TABLE 16
IMPACT OF PORTER’S FIVE FORCES ON PELVIC ORGAN PROLAPSE/PELVIC FLOOR RECONSTRUCTION MARKET
TABLE 17
INFLUENCE OF STAKEHOLDERS ON BUYING PROCESS FOR TOP FOUR PRODUCTS (%)
TABLE 18
KEY BUYING CRITERIA FOR TOP FOUR PRODUCTS
TABLE 19
US-ADJUSTED RECIPROCAL TARIFF RATES
TABLE 20
PELVIC ORGAN PROLAPSE/PELVIC FLOOR RECONSTRUCTION MARKET, BY PRODUCT, 2023–2030 (USD MILLION)
TABLE 21
KEY PRODUCTS IN SYNTHETIC MESH MARKET
TABLE 22
SYNTHETIC MESH SALES, BY COUNTRY, 2023–2030 (UNITS)
TABLE 23
PELVIC ORGAN PROLAPSE/PELVIC FLOOR RECONSTRUCTION MARKET FOR SYNTHETIC MESH, BY REGION, 2023–2030 (USD MILLION)
TABLE 24
NORTH AMERICA: PELVIC ORGAN PROLAPSE/PELVIC FLOOR RECONSTRUCTION MARKET FOR SYNTHETIC MESH, BY COUNTRY, 2023–2030 (USD MILLION)
TABLE 25
EUROPE: PELVIC ORGAN PROLAPSE/PELVIC FLOOR RECONSTRUCTION MARKET FOR SYNTHETIC MESH, BY COUNTRY, 2023–2030 (USD MILLION)
TABLE 26
ASIA PACIFIC: PELVIC ORGAN PROLAPSE/PELVIC FLOOR RECONSTRUCTION MARKET FOR SYNTHETIC MESH, BY COUNTRY, 2023–2030 (USD MILLION)
TABLE 27
LATIN AMERICA: PELVIC ORGAN PROLAPSE/PELVIC FLOOR RECONSTRUCTION MARKET FOR SYNTHETIC MESH, BY COUNTRY, 2023–2030 (USD MILLION)
TABLE 28
KEY PRODUCTS IN BIOLOGICAL GRAFTS MARKET
TABLE 29
PELVIC ORGAN PROLAPSE/PELVIC FLOOR RECONSTRUCTION MARKET FOR BIOLOGICAL GRAFTS, BY REGION, 2023–2030 (USD MILLION)
TABLE 30
NORTH AMERICA: PELVIC ORGAN PROLAPSE/PELVIC FLOOR RECONSTRUCTION MARKET FOR BIOLOGICAL GRAFTS, BY COUNTRY, 2023–2030 (USD MILLION)
TABLE 31
EUROPE: PELVIC ORGAN PROLAPSE/PELVIC FLOOR RECONSTRUCTION MARKET FOR BIOLOGICAL GRAFTS, BY COUNTRY, 2023–2030 (USD MILLION)
TABLE 32
ASIA PACIFIC: PELVIC ORGAN PROLAPSE/PELVIC FLOOR RECONSTRUCTION FOR BIOLOGICAL GRAFTS, BY COUNTRY, 2023–2030 (USD MILLION)
TABLE 33
LATIN AMERICA: PELVIC ORGAN PROLAPSE/PELVIC FLOOR RECONSTRUCTION MARKET FOR BIOLOGICAL GRAFTS, BY COUNTRY, 2023–2030 (USD MILLION)
TABLE 34
KEY PRODUCTS IN SUTURES MARKET
TABLE 35
SUTURE SALES, BY COUNTRY, 2023–2030 (UNITS)
TABLE 36
PELVIC ORGAN PROLAPSE/PELVIC FLOOR RECONSTRUCTION MARKET FOR SUTURES, BY REGION, 2023–2030 (USD MILLION)
TABLE 37
NORTH AMERICA: PELVIC ORGAN PROLAPSE/PELVIC FLOOR RECONSTRUCTION MARKET FOR SUTURES, BY COUNTRY, 2023–2030 (USD MILLION)
TABLE 38
EUROPE: PELVIC ORGAN PROLAPSE/PELVIC FLOOR RECONSTRUCTION MARKET FOR SUTURES, BY COUNTRY, 2023–2030 (USD MILLION)
TABLE 39
ASIA PACIFIC: PELVIC ORGAN PROLAPSE/PELVIC FLOOR RECONSTRUCTION MARKET FOR SUTURES, BY COUNTRY, 2023–2030 (USD MILLION)
TABLE 40
LATIN AMERICA: PELVIC ORGAN PROLAPSE/PELVIC FLOOR RECONSTRUCTION MARKET FOR SUTURES, BY COUNTRY, 2023–2030 (USD MILLION)
TABLE 41
KEY PRODUCTS IN VAGINAL PESSARIES MARKET
TABLE 42
VAGINAL PESSARY SALES, BY COUNTRY, 2023–2030 (UNITS)
TABLE 43
PELVIC ORGAN PROLAPSE/PELVIC FLOOR RECONSTRUCTION MARKET FOR VAGINAL PESSARIES, BY REGION, 2023–2030 (USD MILLION)
TABLE 44
NORTH AMERICA: PELVIC ORGAN PROLAPSE/PELVIC FLOOR RECONSTRUCTION MARKET FOR VAGINAL PESSARIES, BY COUNTRY, 2023–2030 (USD MILLION)
TABLE 45
EUROPE: PELVIC ORGAN PROLAPSE/PELVIC FLOOR RECONSTRUCTION MARKET FOR VAGINAL PESSARIES, BY COUNTRY, 2023–2030 (USD MILLION)
TABLE 46
ASIA PACIFIC: PELVIC ORGAN PROLAPSE/PELVIC FLOOR RECONSTRUCTION MARKET FOR VAGINAL PESSARIES, BY COUNTRY, 2023–2030 (USD MILLION)
TABLE 47
LATIN AMERICA: PELVIC ORGAN PROLAPSE/PELVIC FLOOR RECONSTRUCTION MARKET FOR VAGINAL PESSARIES, BY COUNTRY, 2022–2030 (USD MILLION)
TABLE 48
KEY PRODUCTS IN PELVIC FLOOR THERAPY DEVICES MARKET
TABLE 49
PELVIC ORGAN PROLAPSE/PELVIC FLOOR RECONSTRUCTION MARKET FOR PELVIC FLOOR THERAPY DEVICES, BY REGION, 2023–2030 (USD MILLION)
TABLE 50
NORTH AMERICA: PELVIC ORGAN PROLAPSE/PELVIC FLOOR RECONSTRUCTION MARKET FOR PELVIC FLOOR THERAPY DEVICES, BY COUNTRY, 2023–2030 (USD MILLION)
TABLE 51
EUROPE: PELVIC ORGAN PROLAPSE/PELVIC FLOOR RECONSTRUCTION MARKET FOR PELVIC FLOOR THERAPY DEVICES, BY COUNTRY, 2023–2030 (USD MILLION)
TABLE 52
ASIA PACIFIC: PELVIC ORGAN PROLAPSE/PELVIC FLOOR RECONSTRUCTION MARKET FOR PELVIC FLOOR THERAPY DEVICES, BY COUNTRY, 2023–2030 (USD MILLION)
TABLE 53
LATIN AMERICA: PELVIC ORGAN PROLAPSE/PELVIC FLOOR RECONSTRUCTION MARKET FOR PELVIC FLOOR THERAPY DEVICES, BY COUNTRY, 2023–2030 (USD MILLION)
TABLE 54
KEY PRODUCTS IN ROBOTIC SURGERY SYSTEMS MARKET
TABLE 55
PELVIC ORGAN PROLAPSE/PELVIC FLOOR RECONSTRUCTION MARKET FOR ROBOTIC SURGERY SYSTEMS, BY REGION, 2023–2030 (USD MILLION)
TABLE 56
NORTH AMERICA: PELVIC ORGAN PROLAPSE/PELVIC FLOOR RECONSTRUCTION MARKET FOR ROBOTIC SURGERY SYSTEMS, BY COUNTRY, 2023–2030 (USD MILLION)
TABLE 57
EUROPE: PELVIC ORGAN PROLAPSE/PELVIC FLOOR RECONSTRUCTION MARKET FOR ROBOTIC SURGERY SYSTEMS, BY COUNTRY, 2023–2030 (USD MILLION)
TABLE 58
ASIA PACIFIC: PELVIC ORGAN PROLAPSE/PELVIC FLOOR RECONSTRUCTION MARKET FOR ROBOTIC SURGERY SYSTEMS, BY COUNTRY, 2023–2030 (USD MILLION)
TABLE 59
LATIN AMERICA: PELVIC ORGAN PROLAPSE/PELVIC FLOOR RECONSTRUCTION MARKET FOR ROBOTIC SURGERY SYSTEMS, BY COUNTRY, 2023–2030 (USD MILLION)
TABLE 60
KEY PRODUCTS IN DIAGNOSTIC & ASSESSMENT TOOLS MARKET
TABLE 61
PELVIC ORGAN PROLAPSE/PELVIC FLOOR RECONSTRUCTION MARKET FOR DIAGNOSTIC & ASSESSMENT TOOLS, BY REGION, 2023–2030 (USD MILLION)
TABLE 62
NORTH AMERICA: PELVIC ORGAN PROLAPSE/PELVIC FLOOR RECONSTRUCTION MARKET FOR DIAGNOSTIC & ASSESSMENT TOOLS, BY COUNTRY, 2023–2030 (USD MILLION)
TABLE 63
EUROPE: PELVIC ORGAN PROLAPSE/PELVIC FLOOR RECONSTRUCTION MARKET FOR DIAGNOSTIC & ASSESSMENT TOOLS, BY COUNTRY, 2023–2030 (USD MILLION)
TABLE 64
ASIA PACIFIC: PELVIC ORGAN PROLAPSE/PELVIC FLOOR RECONSTRUCTION MARKET FOR DIAGNOSTIC & ASSESSMENT TOOLS, BY COUNTRY, 2023–2030 (USD MILLION)
TABLE 65
LATIN AMERICA: PELVIC ORGAN PROLAPSE/PELVIC FLOOR RECONSTRUCTION MARKET FOR DIAGNOSTIC & ASSESSMENT TOOLS, BY COUNTRY, 2023–2030 (USD MILLION)
TABLE 66
PELVIC ORGAN PROLAPSE/PELVIC FLOOR RECONSTRUCTION MARKET, BY TREATMENT, 2023–2030 (USD MILLION)
TABLE 67
PELVIC ORGAN PROLAPSE/PELVIC FLOOR RECONSTRUCTION MARKET FOR SURGICAL, BY TYPE, 2023–2030 (USD MILLION)
TABLE 68
PELVIC ORGAN PROLAPSE/PELVIC FLOOR RECONSTRUCTION MARKET FOR SURGICAL, BY REGION, 2023–2030 (USD MILLION)
TABLE 69
NORTH AMERICA: PELVIC ORGAN PROLAPSE/PELVIC FLOOR RECONSTRUCTION MARKET FOR SURGICAL, BY COUNTRY, 2023–2030 (USD MILLION)
TABLE 70
EUROPE: PELVIC ORGAN PROLAPSE/PELVIC FLOOR RECONSTRUCTION MARKET FOR SURGICAL, BY COUNTRY, 2023–2030 (USD MILLION)
TABLE 71
ASIA PACIFIC: PELVIC ORGAN PROLAPSE/PELVIC FLOOR RECONSTRUCTION MARKET FOR SURGICAL, BY COUNTRY, 2023–2030 (USD MILLION)
TABLE 72
LATIN AMERICA: PELVIC ORGAN PROLAPSE/PELVIC FLOOR RECONSTRUCTION MARKET FOR SURGICAL, BY COUNTRY, 2023–2030 (USD MILLION)
TABLE 73
PELVIC ORGAN PROLAPSE/PELVIC FLOOR RECONSTRUCTION MARKET FOR COLPOCLEISIS, BY REGION, 2023–2030 (USD MILLION)
TABLE 74
NORTH AMERICA: PELVIC ORGAN PROLAPSE/PELVIC FLOOR RECONSTRUCTION MARKET FOR COLPOCLEISIS, BY COUNTRY, 2023–2030 (USD MILLION)
TABLE 75
EUROPE: PELVIC ORGAN PROLAPSE/PELVIC FLOOR RECONSTRUCTION MARKET FOR COLPOCLEISIS, BY COUNTRY, 2023–2030 (USD MILLION)
TABLE 76
ASIA PACIFIC: PELVIC ORGAN PROLAPSE/PELVIC FLOOR RECONSTRUCTION FOR COLPOCLEISIS, BY COUNTRY, 2023–2030 (USD MILLION)
TABLE 77
LATIN AMERICA: PELVIC ORGAN PROLAPSE/PELVIC FLOOR RECONSTRUCTION MARKET FOR COLPOCLEISIS, BY COUNTRY, 2023–2030 (USD MILLION)
TABLE 78
PELVIC ORGAN PROLAPSE/PELVIC FLOOR RECONSTRUCTION MARKET FOR COLPORRHAPY, BY REGION, 2023–2030 (USD MILLION)
TABLE 79
NORTH AMERICA: PELVIC ORGAN PROLAPSE/PELVIC FLOOR RECONSTRUCTION MARKET FOR COLPORRHAPY, BY COUNTRY, 2023–2030 (USD MILLION)
TABLE 80
EUROPE: PELVIC ORGAN PROLAPSE/PELVIC FLOOR RECONSTRUCTION MARKET FOR COLPORRHAPY, BY COUNTRY, 2023–2030 (USD MILLION)
TABLE 81
ASIA PACIFIC: PELVIC ORGAN PROLAPSE/PELVIC FLOOR RECONSTRUCTION MARKET FOR COLPORRHAPY, BY COUNTRY, 2023–2030 (USD MILLION)
TABLE 82
LATIN AMERICA: PELVIC ORGAN PROLAPSE/PELVIC FLOOR RECONSTRUCTION MARKET FOR COLPORRHAPY, BY COUNTRY, 2023–2030 (USD MILLION)
TABLE 83
PELVIC ORGAN PROLAPSE/PELVIC FLOOR RECONSTRUCTION MARKET FOR SACROCOLPOPEXY, BY REGION, 2023–2030 (USD MILLION)
TABLE 84
NORTH AMERICA: PELVIC ORGAN PROLAPSE/PELVIC FLOOR RECONSTRUCTION MARKET FOR SACROCOLPOPEXY, BY COUNTRY, 2023–2030 (USD MILLION)
TABLE 85
EUROPE: PELVIC ORGAN PROLAPSE/PELVIC FLOOR RECONSTRUCTION MARKET FOR SACROCOLPOPEXY, BY COUNTRY, 2023–2030 (USD MILLION)
TABLE 86
ASIA PACIFIC: PELVIC ORGAN PROLAPSE/PELVIC FLOOR RECONSTRUCTION MARKET FOR SACROCOLPOPEXY, BY COUNTRY, 2023–2030 (USD MILLION)
TABLE 87
LATIN AMERICA: PELVIC ORGAN PROLAPSE/PELVIC FLOOR RECONSTRUCTION MARKET FOR SACROCOLPOPEXY, BY COUNTRY, 2022–2030 (USD MILLION)
TABLE 88
PELVIC ORGAN PROLAPSE/PELVIC FLOOR RECONSTRUCTION MARKET FOR SACROHYSTEROPEXY, BY REGION, 2023–2030 (USD MILLION)
TABLE 89
NORTH AMERICA: PELVIC ORGAN PROLAPSE/PELVIC FLOOR RECONSTRUCTION MARKET FOR SACROHYSTEROPEXY, BY COUNTRY, 2023–2030 (USD MILLION)
TABLE 90
EUROPE: PELVIC ORGAN PROLAPSE/PELVIC FLOOR RECONSTRUCTION MARKET FOR SACROHYSTEROPEXY, BY COUNTRY, 2023–2030 (USD MILLION)
TABLE 91
ASIA PACIFIC: PELVIC ORGAN PROLAPSE/PELVIC FLOOR RECONSTRUCTION MARKET FOR SACROHYSTEROPEXY, BY COUNTRY, 2023–2030 (USD MILLION)
TABLE 92
LATIN AMERICA: PELVIC ORGAN PROLAPSE/PELVIC FLOOR RECONSTRUCTION MARKET FOR SACROHYSTEROPEXY, BY COUNTRY, 2022–2030 (USD MILLION)
TABLE 93
PELVIC ORGAN PROLAPSE/PELVIC FLOOR RECONSTRUCTION MARKET FOR UTEROSACRAL OR SACROSPINOUS LIGAMENT FIXATION, BY REGION, 2023–2030 (USD MILLION)
TABLE 94
NORTH AMERICA: PELVIC ORGAN PROLAPSE/PELVIC FLOOR RECONSTRUCTION MARKET FOR UTEROSACRAL OR SACROSPINOUS LIGAMENT FIXATION, BY COUNTRY, 2023–2030 (USD MILLION)
TABLE 95
EUROPE: PELVIC ORGAN PROLAPSE/PELVIC FLOOR RECONSTRUCTION MARKET FOR UTEROSACRAL OR SACROSPINOUS LIGAMENT FIXATION, BY COUNTRY, 2023–2030 (USD MILLION)
TABLE 96
ASIA PACIFIC: PELVIC ORGAN PROLAPSE/PELVIC FLOOR RECONSTRUCTION MARKET FOR UTEROSACRAL OR SACROSPINOUS LIGAMENT FIXATION, BY COUNTRY, 2023–2030 (USD MILLION)
TABLE 97
LATIN AMERICA: PELVIC ORGAN PROLAPSE/PELVIC FLOOR RECONSTRUCTION MARKET FOR UTEROSACRAL OR SACROSPINOUS LIGAMENT FIXATION, BY COUNTRY, 2022–2030 (USD MILLION)
TABLE 98
PELVIC ORGAN PROLAPSE/PELVIC FLOOR RECONSTRUCTION MARKET FOR NON-SURGICAL, BY TYPE, 2023–2030 (USD MILLION)
TABLE 99
PELVIC ORGAN PROLAPSE/PELVIC FLOOR RECONSTRUCTION MARKET FOR NON-SURGICAL, BY REGION, 2023–2030 (USD MILLION)
TABLE 100
NORTH AMERICA: PELVIC ORGAN PROLAPSE/PELVIC FLOOR RECONSTRUCTION MARKET FOR NON-SURGICAL, BY COUNTRY, 2023–2030 (USD MILLION)
TABLE 101
EUROPE: PELVIC ORGAN PROLAPSE/PELVIC FLOOR RECONSTRUCTION MARKET FOR NON-SURGICAL, BY COUNTRY, 2023–2030 (USD MILLION)
TABLE 102
ASIA PACIFIC: PELVIC ORGAN PROLAPSE/PELVIC FLOOR RECONSTRUCTION MARKET FOR NON-SURGICAL, BY COUNTRY, 2023–2030 (USD MILLION)
TABLE 103
LATIN AMERICA: PELVIC ORGAN PROLAPSE/PELVIC FLOOR RECONSTRUCTION MARKET FOR NON-SURGICAL, BY COUNTRY, 2023–2030 (USD MILLION)
TABLE 104
PELVIC ORGAN PROLAPSE/PELVIC FLOOR RECONSTRUCTION MARKET FOR VAGINAL PESSARY MANAGEMENT, BY REGION, 2023–2030 (USD MILLION)
TABLE 105
NORTH AMERICA: PELVIC ORGAN PROLAPSE/PELVIC FLOOR RECONSTRUCTION MARKET FOR VAGINAL PESSARY MANAGEMENT, BY COUNTRY, 2023–2030 (USD MILLION)
TABLE 106
EUROPE: PELVIC ORGAN PROLAPSE/PELVIC FLOOR RECONSTRUCTION MARKET FOR VAGINAL PESSARY MANAGEMENT, BY COUNTRY, 2023–2030 (USD MILLION)
TABLE 107
ASIA PACIFIC: PELVIC ORGAN PROLAPSE/PELVIC FLOOR RECONSTRUCTION FOR VAGINAL PESSARY MANAGEMENT, BY COUNTRY, 2023–2030 (USD MILLION)
TABLE 108
LATIN AMERICA: PELVIC ORGAN PROLAPSE/PELVIC FLOOR RECONSTRUCTION MARKET FOR VAGINAL PESSARY MANAGEMENT, BY COUNTRY, 2023–2030 (USD MILLION)
TABLE 109
PELVIC ORGAN PROLAPSE/PELVIC FLOOR RECONSTRUCTION MARKET FOR PELVIC FLOOR MUSCLE THERAPY, BY REGION, 2023–2030 (USD MILLION)
TABLE 110
NORTH AMERICA: PELVIC ORGAN PROLAPSE/PELVIC FLOOR RECONSTRUCTION MARKET FOR PELVIC FLOOR MUSCLE THERAPY, BY COUNTRY, 2023–2030 (USD MILLION)
TABLE 111
EUROPE: PELVIC ORGAN PROLAPSE/PELVIC FLOOR RECONSTRUCTION MARKET FOR PELVIC FLOOR MUSCLE THERAPY, BY COUNTRY, 2023–2030 (USD MILLION)
TABLE 112
ASIA PACIFIC: PELVIC ORGAN PROLAPSE/PELVIC FLOOR RECONSTRUCTION MARKET FOR PELVIC FLOOR MUSCLE THERAPY, BY COUNTRY, 2023–2030 (USD MILLION)
TABLE 113
LATIN AMERICA: PELVIC ORGAN PROLAPSE/PELVIC FLOOR RECONSTRUCTION MARKET FOR PELVIC FLOOR MUSCLE THERAPY, BY COUNTRY, 2023–2030 (USD MILLION)
TABLE 114
PELVIC ORGAN PROLAPSE/PELVIC FLOOR RECONSTRUCTION MARKET, BY APPLICATION, 2023–2030 (USD MILLION)
TABLE 115
PELVIC ORGAN PROLAPSE/PELVIC FLOOR RECONSTRUCTION MARKET FOR CYSTOCELE, BY REGION, 2023–2030 (USD MILLION)
TABLE 116
NORTH AMERICA: PELVIC ORGAN PROLAPSE/PELVIC FLOOR RECONSTRUCTION MARKET FOR CYSTOCELE, BY COUNTRY, 2023–2030 (USD MILLION)
TABLE 117
EUROPE: PELVIC ORGAN PROLAPSE/PELVIC FLOOR RECONSTRUCTION MARKET FOR CYSTOCELE, BY COUNTRY, 2023–2030 (USD MILLION)
TABLE 118
ASIA PACIFIC: PELVIC ORGAN PROLAPSE/PELVIC FLOOR RECONSTRUCTION MARKET FOR CYSTOCELE, BY COUNTRY, 2023–2030 (USD MILLION)
TABLE 119
LATIN AMERICA: PELVIC ORGAN PROLAPSE/PELVIC FLOOR RECONSTRUCTION MARKET FOR CYSTOCELE, BY COUNTRY, 2023–2030 (USD MILLION)
TABLE 120
PELVIC ORGAN PROLAPSE/PELVIC FLOOR RECONSTRUCTION MARKET FOR URETHROCELE, BY REGION, 2023–2030 (USD MILLION)
TABLE 121
NORTH AMERICA: PELVIC ORGAN PROLAPSE/PELVIC FLOOR RECONSTRUCTION MARKET FOR URETHROCELE, BY COUNTRY, 2023–2030 (USD MILLION)
TABLE 122
EUROPE: PELVIC ORGAN PROLAPSE/PELVIC FLOOR RECONSTRUCTION MARKET FOR URETHROCELE, BY COUNTRY, 2023–2030 (USD MILLION)
TABLE 123
ASIA PACIFIC: PELVIC ORGAN PROLAPSE/PELVIC FLOOR RECONSTRUCTION FOR URETHROCELE, BY COUNTRY, 2023–2030 (USD MILLION)
TABLE 124
LATIN AMERICA: PELVIC ORGAN PROLAPSE/PELVIC FLOOR RECONSTRUCTION MARKET FOR URETHROCELE, BY COUNTRY, 2023–2030 (USD MILLION)
TABLE 125
PELVIC ORGAN PROLAPSE/PELVIC FLOOR RECONSTRUCTION MARKET FOR ENTEROCELE, BY REGION, 2023–2030 (USD MILLION)
TABLE 126
NORTH AMERICA: PELVIC ORGAN PROLAPSE/PELVIC FLOOR RECONSTRUCTION MARKET FOR ENTEROCELE, BY COUNTRY, 2023–2030 (USD MILLION)
TABLE 127
EUROPE: PELVIC ORGAN PROLAPSE/PELVIC FLOOR RECONSTRUCTION MARKET FOR ENTEROCELE, BY COUNTRY, 2023–2030 (USD MILLION)
TABLE 128
ASIA PACIFIC: PELVIC ORGAN PROLAPSE/PELVIC FLOOR RECONSTRUCTION MARKET FOR ENTEROCELE, BY COUNTRY, 2023–2030 (USD MILLION)
TABLE 129
LATIN AMERICA: PELVIC ORGAN PROLAPSE/PELVIC FLOOR RECONSTRUCTION MARKET FOR ENTEROCELE, BY COUNTRY, 2023–2030 (USD MILLION)
TABLE 130
PELVIC ORGAN PROLAPSE/PELVIC FLOOR RECONSTRUCTION MARKET FOR UTERINE PROLAPSE, BY REGION, 2023–2030 (USD MILLION)
TABLE 131
NORTH AMERICA: PELVIC ORGAN PROLAPSE/PELVIC FLOOR RECONSTRUCTION MARKET FOR UTERINE PROLAPSE, BY COUNTRY, 2023–2030 (USD MILLION)
TABLE 132
EUROPE: PELVIC ORGAN PROLAPSE/PELVIC FLOOR RECONSTRUCTION MARKET FOR UTERINE PROLAPSE, BY COUNTRY, 2023–2030 (USD MILLION)
TABLE 133
ASIA PACIFIC: PELVIC ORGAN PROLAPSE/PELVIC FLOOR RECONSTRUCTION MARKET FOR UTERINE PROLAPSE, BY COUNTRY, 2023–2030 (USD MILLION)
TABLE 134
LATIN AMERICA: PELVIC ORGAN PROLAPSE/PELVIC FLOOR RECONSTRUCTION MARKET FOR UTERINE PROLAPSE, BY COUNTRY, 2022–2030 (USD MILLION)
TABLE 135
PELVIC ORGAN PROLAPSE/PELVIC FLOOR RECONSTRUCTION MARKET FOR RECTOCELE, BY REGION, 2023–2030 (USD MILLION)
TABLE 136
NORTH AMERICA: PELVIC ORGAN PROLAPSE/PELVIC FLOOR RECONSTRUCTION MARKET FOR RECTOCELE, BY COUNTRY, 2023–2030 (USD MILLION)
TABLE 137
EUROPE: PELVIC ORGAN PROLAPSE/PELVIC FLOOR RECONSTRUCTION MARKET FOR RECTOCELE, BY COUNTRY, 2023–2030 (USD MILLION)
TABLE 138
ASIA PACIFIC: PELVIC ORGAN PROLAPSE/PELVIC FLOOR RECONSTRUCTION MARKET FOR RECTOCELE, BY COUNTRY, 2023–2030 (USD MILLION)
TABLE 139
LATIN AMERICA: PELVIC ORGAN PROLAPSE/PELVIC FLOOR RECONSTRUCTION MARKET FOR RECTOCELE, BY COUNTRY, 2023–2030 (USD MILLION)
TABLE 140
PELVIC ORGAN PROLAPSE/PELVIC FLOOR RECONSTRUCTION MARKET, BY END USER, 2023–2030 (USD MILLION)
TABLE 141
HOSPITALS PER CAPITA, BY COUNTRY, 2024
TABLE 142
PELVIC ORGAN PROLAPSE/PELVIC FLOOR RECONSTRUCTION MARKET FOR HOSPITALS, BY REGION, 2023–2030 (USD MILLION)
TABLE 143
NORTH AMERICA: PELVIC ORGAN PROLAPSE/PELVIC FLOOR RECONSTRUCTION MARKET FOR HOSPITALS, BY COUNTRY, 2023–2030 (USD MILLION)
TABLE 144
EUROPE: PELVIC ORGAN PROLAPSE/PELVIC FLOOR RECONSTRUCTION MARKET FOR HOSPITALS, BY COUNTRY, 2023–2030 (USD MILLION)
TABLE 145
ASIA PACIFIC: PELVIC ORGAN PROLAPSE/PELVIC FLOOR RECONSTRUCTION MARKET FOR HOSPITALS, BY COUNTRY, 2023–2030 (USD MILLION)
TABLE 146
LATIN AMERICA: PELVIC ORGAN PROLAPSE/PELVIC FLOOR RECONSTRUCTION MARKET FOR HOSPITALS, BY COUNTRY, 2023–2030 (USD MILLION)
TABLE 147
PELVIC ORGAN PROLAPSE/PELVIC FLOOR RECONSTRUCTION MARKET FOR SPECIALTY CLINICS, BY REGION, 2023–2030 (USD MILLION)
TABLE 148
NORTH AMERICA: PELVIC ORGAN PROLAPSE/PELVIC FLOOR RECONSTRUCTION MARKET FOR SPECIALTY CLINICS, BY COUNTRY, 2023–2030 (USD MILLION)
TABLE 149
EUROPE: PELVIC ORGAN PROLAPSE/PELVIC FLOOR RECONSTRUCTION MARKET FOR SPECIALTY CLINICS, BY COUNTRY, 2023–2030 (USD MILLION)
TABLE 150
ASIA PACIFIC: PELVIC ORGAN PROLAPSE/PELVIC FLOOR RECONSTRUCTION FOR SPECIALTY CLINICS, BY COUNTRY, 2023–2030 (USD MILLION)
TABLE 151
LATIN AMERICA: PELVIC ORGAN PROLAPSE/PELVIC FLOOR RECONSTRUCTION MARKET FOR SPECIALTY CLINICS, BY COUNTRY, 2023–2030 (USD MILLION)
TABLE 152
PELVIC ORGAN PROLAPSE/PELVIC FLOOR RECONSTRUCTION MARKET FOR AMBULATORY SURGERY CENTERS, BY REGION, 2023–2030 (USD MILLION)
TABLE 153
NORTH AMERICA: PELVIC ORGAN PROLAPSE/PELVIC FLOOR RECONSTRUCTION MARKET FOR AMBULATORY SURGERY CENTERS, BY COUNTRY, 2023–2030 (USD MILLION)
TABLE 154
EUROPE: PELVIC ORGAN PROLAPSE/PELVIC FLOOR RECONSTRUCTION MARKET FOR AMBULATORY SURGERY CENTERS, BY COUNTRY, 2023–2030 (USD MILLION)
TABLE 155
ASIA PACIFIC: PELVIC ORGAN PROLAPSE/PELVIC FLOOR RECONSTRUCTION MARKET FOR AMBULATORY SURGERY CENTERS, BY COUNTRY, 2023–2030 (USD MILLION)
TABLE 156
LATIN AMERICA: PELVIC ORGAN PROLAPSE/PELVIC FLOOR RECONSTRUCTION MARKET FOR AMBULATORY SURGERY CENTERS, BY COUNTRY, 2023–2030 (USD MILLION)
TABLE 157
PELVIC ORGAN PROLAPSE/PELVIC FLOOR RECONSTRUCTION MARKET FOR OTHER END USERS, BY REGION, 2023–2030 (USD MILLION)
TABLE 158
NORTH AMERICA: PELVIC ORGAN PROLAPSE/PELVIC FLOOR RECONSTRUCTION MARKET FOR OTHER END USERS, BY COUNTRY, 2023–2030 (USD MILLION)
TABLE 159
EUROPE: PELVIC ORGAN PROLAPSE/PELVIC FLOOR RECONSTRUCTION MARKET FOR OTHER END USERS, BY COUNTRY, 2023–2030 (USD MILLION)
TABLE 160
ASIA PACIFIC: PELVIC ORGAN PROLAPSE/PELVIC FLOOR RECONSTRUCTION MARKET FOR OTHER END USERS, BY COUNTRY, 2023–2030 (USD MILLION)
TABLE 161
LATIN AMERICA: PELVIC ORGAN PROLAPSE/PELVIC FLOOR RECONSTRUCTION MARKET FOR OTHER END USERS, BY COUNTRY, 2022–2030 (USD MILLION)
TABLE 162
PELVIC ORGAN PROLAPSE/PELVIC FLOOR RECONSTRUCTION MARKET, BY REGION, 2023–2030 (USD MILLION)
TABLE 163
NORTH AMERICA: MACROECONOMIC INDICATORS
TABLE 164
NORTH AMERICA: PELVIC ORGAN PROLAPSE/PELVIC FLOOR RECONSTRUCTION MARKET, BY COUNTRY, 2023–2030 (USD MILLION)
TABLE 165
NORTH AMERICA: PELVIC ORGAN PROLAPSE/PELVIC FLOOR RECONSTRUCTION MARKET, BY PRODUCT, 2023–2030 (USD MILLION)
TABLE 166
NORTH AMERICA: PELVIC ORGAN PROLAPSE/PELVIC FLOOR RECONSTRUCTION MARKET, BY TREATMENT, 2023–2030 (USD MILLION)
TABLE 167
NORTH AMERICA: SURGICAL PELVIC ORGAN PROLAPSE/PELVIC FLOOR RECONSTRUCTION MARKET, BY TYPE, 2023–2030 (USD MILLION)
TABLE 168
NORTH AMERICA: NON-SURGICAL PELVIC ORGAN PROLAPSE/PELVIC FLOOR RECONSTRUCTION MARKET, BY TYPE, 2023–2030 (USD MILLION)
TABLE 169
NORTH AMERICA: PELVIC ORGAN PROLAPSE/PELVIC FLOOR RECONSTRUCTION MARKET, BY APPLICATION, 2023–2030 (USD MILLION)
TABLE 170
NORTH AMERICA: PELVIC ORGAN PROLAPSE/PELVIC FLOOR RECONSTRUCTION MARKET, BY END USER, 2023–2030 (USD MILLION)
TABLE 171
US: PELVIC ORGAN PROLAPSE/PELVIC FLOOR RECONSTRUCTION MARKET, BY PRODUCT, 2023–2030 (USD MILLION)
TABLE 172
US: PELVIC ORGAN PROLAPSE/PELVIC FLOOR RECONSTRUCTION MARKET, BY TREATMENT, 2023–2030 (USD MILLION)
TABLE 173
US: SURGICAL PELVIC ORGAN PROLAPSE/PELVIC FLOOR RECONSTRUCTION MARKET, BY TYPE, 2023–2030 (USD MILLION)
TABLE 174
US: NON-SURGICAL PELVIC ORGAN PROLAPSE/PELVIC FLOOR RECONSTRUCTION MARKET, BY TYPE, 2023–2030 (USD MILLION)
TABLE 175
US: PELVIC ORGAN PROLAPSE/PELVIC FLOOR RECONSTRUCTION MARKET, BY APPLICATION, 2023–2030 (USD MILLION)
TABLE 176
US: PELVIC ORGAN PROLAPSE/PELVIC FLOOR RECONSTRUCTION MARKET, BY END USER, 2023–2030 (USD MILLION)
TABLE 177
CANADA: PELVIC ORGAN PROLAPSE/PELVIC FLOOR RECONSTRUCTION MARKET, BY PRODUCT, 2023–2030 (USD MILLION)
TABLE 178
CANADA: PELVIC ORGAN PROLAPSE/PELVIC FLOOR RECONSTRUCTION MARKET, BY TREATMENT, 2023–2030 (USD MILLION)
TABLE 179
CANADA: SURGICAL PELVIC ORGAN PROLAPSE/PELVIC FLOOR RECONSTRUCTION MARKET, BY TYPE, 2023–2030 (USD MILLION)
TABLE 180
CANADA: NON-SURGICAL PELVIC ORGAN PROLAPSE/PELVIC FLOOR RECONSTRUCTION MARKET, BY TYPE, 2023–2030 (USD MILLION)
TABLE 181
CANADA: PELVIC ORGAN PROLAPSE/PELVIC FLOOR RECONSTRUCTION MARKET, BY APPLICATION, 2023–2030 (USD MILLION)
TABLE 182
CANADA: PELVIC ORGAN PROLAPSE/PELVIC FLOOR RECONSTRUCTION MARKET, BY END USER, 2023–2030 (USD MILLION)
TABLE 183
EUROPE: MACROECONOMIC INDICATORS
TABLE 184
EUROPE: PELVIC ORGAN PROLAPSE/PELVIC FLOOR RECONSTRUCTION MARKET, BY COUNTRY, 2023–2030 (USD MILLION)
TABLE 185
EUROPE: PELVIC ORGAN PROLAPSE/PELVIC FLOOR RECONSTRUCTION MARKET, BY PRODUCT, 2023–2030 (USD MILLION)
TABLE 186
EUROPE: PELVIC ORGAN PROLAPSE/PELVIC FLOOR RECONSTRUCTION MARKET, BY TREATMENT, 2023–2030 (USD MILLION)
TABLE 187
EUROPE: SURGICAL PELVIC ORGAN PROLAPSE/PELVIC FLOOR RECONSTRUCTION MARKET, BY TYPE, 2023–2030 (USD MILLION)
TABLE 188
EUROPE: NON-SURGICAL PELVIC ORGAN PROLAPSE/PELVIC FLOOR RECONSTRUCTION MARKET, BY TYPE, 2023–2030 (USD MILLION)
TABLE 189
EUROPE: PELVIC ORGAN PROLAPSE/PELVIC FLOOR RECONSTRUCTION MARKET, BY APPLICATION, 2023–2030 (USD MILLION)
TABLE 190
EUROPE: PELVIC ORGAN PROLAPSE/PELVIC FLOOR RECONSTRUCTION MARKET, BY END USER, 2023–2030 (USD MILLION)
TABLE 191
GERMANY: PELVIC ORGAN PROLAPSE/PELVIC FLOOR RECONSTRUCTION MARKET, BY PRODUCT, 2023–2030 (USD MILLION)
TABLE 192
GERMANY: PELVIC ORGAN PROLAPSE/PELVIC FLOOR RECONSTRUCTION MARKET, BY TREATMENT, 2023–2030 (USD MILLION)
TABLE 193
GERMANY: SURGICAL PELVIC ORGAN PROLAPSE/PELVIC FLOOR RECONSTRUCTION MARKET, BY TYPE, 2023–2030 (USD MILLION)
TABLE 194
GERMANY: NON-SURGICAL PELVIC ORGAN PROLAPSE/PELVIC FLOOR RECONSTRUCTION MARKET, BY TYPE, 2023–2030 (USD MILLION)
TABLE 195
GERMANY: PELVIC ORGAN PROLAPSE/PELVIC FLOOR RECONSTRUCTION MARKET, BY APPLICATION, 2023–2030 (USD MILLION)
TABLE 196
GERMANY: PELVIC ORGAN PROLAPSE/PELVIC FLOOR RECONSTRUCTION MARKET, BY END USER, 2023–2030 (USD MILLION)
TABLE 197
FRANCE: PELVIC ORGAN PROLAPSE/PELVIC FLOOR RECONSTRUCTION MARKET, BY PRODUCT, 2023–2030 (USD MILLION)
TABLE 198
FRANCE: PELVIC ORGAN PROLAPSE/PELVIC FLOOR RECONSTRUCTION MARKET, BY TREATMENT, 2023–2030 (USD MILLION)
TABLE 199
FRANCE: SURGICAL PELVIC ORGAN PROLAPSE/PELVIC FLOOR RECONSTRUCTION MARKET, BY TYPE, 2023–2030 (USD MILLION)
TABLE 200
FRANCE: NON-SURGICAL PELVIC ORGAN PROLAPSE/PELVIC FLOOR RECONSTRUCTION MARKET, BY TYPE, 2023–2030 (USD MILLION)
TABLE 201
FRANCE: PELVIC ORGAN PROLAPSE/PELVIC FLOOR RECONSTRUCTION MARKET, BY APPLICATION, 2023–2030 (USD MILLION)
TABLE 202
FRANCE: PELVIC ORGAN PROLAPSE/PELVIC FLOOR RECONSTRUCTION MARKET, BY END USER, 2023–2030 (USD MILLION)
TABLE 203
UK: PELVIC ORGAN PROLAPSE/PELVIC FLOOR RECONSTRUCTION MARKET, BY PRODUCT, 2023–2030 (USD MILLION)
TABLE 204
UK: PELVIC ORGAN PROLAPSE/PELVIC FLOOR RECONSTRUCTION MARKET, BY TREATMENT, 2023–2030 (USD MILLION)
TABLE 205
UK: SURGICAL PELVIC ORGAN PROLAPSE/PELVIC FLOOR RECONSTRUCTION MARKET, BY TYPE, 2023–2030 (USD MILLION)
TABLE 206
UK: NON-SURGICAL PELVIC ORGAN PROLAPSE/PELVIC FLOOR RECONSTRUCTION MARKET, BY TYPE, 2023–2030 (USD MILLION)
TABLE 207
UK: PELVIC ORGAN PROLAPSE/PELVIC FLOOR RECONSTRUCTION MARKET, BY APPLICATION, 2023–2030 (USD MILLION)
TABLE 208
UK: PELVIC ORGAN PROLAPSE/PELVIC FLOOR RECONSTRUCTION MARKET, BY END USER, 2023–2030 (USD MILLION)
TABLE 209
ITALY: PELVIC ORGAN PROLAPSE/PELVIC FLOOR RECONSTRUCTION MARKET, BY PRODUCT, 2023–2030 (USD MILLION)
TABLE 210
ITALY: PELVIC ORGAN PROLAPSE/PELVIC FLOOR RECONSTRUCTION MARKET, BY TREATMENT, 2023–2030 (USD MILLION)
TABLE 211
ITALY: SURGICAL PELVIC ORGAN PROLAPSE/PELVIC FLOOR RECONSTRUCTION MARKET, BY TYPE, 2023–2030 (USD MILLION)
TABLE 212
ITALY: NON-SURGICAL PELVIC ORGAN PROLAPSE/PELVIC FLOOR RECONSTRUCTION MARKET, BY TYPE, 2023–2030 (USD MILLION)
TABLE 213
ITALY: PELVIC ORGAN PROLAPSE/PELVIC FLOOR RECONSTRUCTION MARKET, BY APPLICATION, 2023–2030 (USD MILLION)
TABLE 214
ITALY: PELVIC ORGAN PROLAPSE/PELVIC FLOOR RECONSTRUCTION MARKET, BY END USER, 2023–2030 (USD MILLION)
TABLE 215
SPAIN: PELVIC ORGAN PROLAPSE/PELVIC FLOOR RECONSTRUCTION MARKET, BY PRODUCT, 2023–2030 (USD MILLION)
TABLE 216
SPAIN: PELVIC ORGAN PROLAPSE/PELVIC FLOOR RECONSTRUCTION MARKET, BY TREATMENT, 2023–2030 (USD MILLION)
TABLE 217
SPAIN: SURGICAL PELVIC ORGAN PROLAPSE/PELVIC FLOOR RECONSTRUCTION MARKET, BY TYPE, 2023–2030 (USD MILLION)
TABLE 218
SPAIN: NON-SURGICAL PELVIC ORGAN PROLAPSE/PELVIC FLOOR RECONSTRUCTION MARKET, BY TYPE, 2023–2030 (USD MILLION)
TABLE 219
SPAIN: PELVIC ORGAN PROLAPSE/PELVIC FLOOR RECONSTRUCTION MARKET, BY APPLICATION, 2023–2030 (USD MILLION)
TABLE 220
SPAIN: PELVIC ORGAN PROLAPSE/PELVIC FLOOR RECONSTRUCTION MARKET, BY END USER, 2023–2030 (USD MILLION)
TABLE 221
REST OF EUROPE: PELVIC ORGAN PROLAPSE/PELVIC FLOOR RECONSTRUCTION MARKET, BY PRODUCT, 2023–2030 (USD MILLION)
TABLE 222
REST OF EUROPE: PELVIC ORGAN PROLAPSE/PELVIC FLOOR RECONSTRUCTION MARKET, BY TREATMENT, 2023–2030 (USD MILLION)
TABLE 223
REST OF EUROPE: SURGICAL PELVIC ORGAN PROLAPSE/PELVIC FLOOR RECONSTRUCTION MARKET, BY TYPE, 2023–2030 (USD MILLION)
TABLE 224
REST OF EUROPE: NON-SURGICAL PELVIC ORGAN PROLAPSE/PELVIC FLOOR RECONSTRUCTION MARKET, BY TYPE, 2023–2030 (USD MILLION)
TABLE 225
REST OF EUROPE: PELVIC ORGAN PROLAPSE/PELVIC FLOOR RECONSTRUCTION MARKET, BY APPLICATION, 2023–2030 (USD MILLION)
TABLE 226
REST OF EUROPE: PELVIC ORGAN PROLAPSE/PELVIC FLOOR RECONSTRUCTION MARKET, BY END USER, 2023–2030 (USD MILLION)
TABLE 227
ASIA PACIFIC: KEY MACROECONOMIC INDICATORS
TABLE 228
ASIA PACIFIC: PELVIC ORGAN PROLAPSE/PELVIC FLOOR RECONSTRUCTION MARKET, BY COUNTRY, 2023–2030 (USD MILLION)
TABLE 229
ASIA PACIFIC: PELVIC ORGAN PROLAPSE/PELVIC FLOOR RECONSTRUCTION MARKET, BY PRODUCT, 2023–2030 (USD MILLION)
TABLE 230
ASIA PACIFIC: PELVIC ORGAN PROLAPSE/PELVIC FLOOR RECONSTRUCTION MARKET, BY TREATMENT, 2023–2030 (USD MILLION)
TABLE 231
ASIA PACIFIC: SURGICAL PELVIC ORGAN PROLAPSE/PELVIC FLOOR RECONSTRUCTION MARKET, BY TYPE, 2023–2030 (USD MILLION)
TABLE 232
ASIA PACIFIC: NON-SURGICAL PELVIC ORGAN PROLAPSE/PELVIC FLOOR RECONSTRUCTION MARKET, BY TYPE, 2023–2030 (USD MILLION)
TABLE 233
ASIA PACIFIC: PELVIC ORGAN PROLAPSE/PELVIC FLOOR RECONSTRUCTION MARKET, BY APPLICATION, 2023–2030 (USD MILLION)
TABLE 234
ASIA PACIFIC: PELVIC ORGAN PROLAPSE/PELVIC FLOOR RECONSTRUCTION MARKET, BY END USER, 2023–2030 (USD MILLION)
TABLE 235
CHINA: PELVIC ORGAN PROLAPSE/PELVIC FLOOR RECONSTRUCTION MARKET, BY PRODUCT, 2023–2030 (USD MILLION)
TABLE 236
CHINA: PELVIC ORGAN PROLAPSE/PELVIC FLOOR RECONSTRUCTION MARKET, BY TREATMENT, 2023–2030 (USD MILLION)
TABLE 237
CHINA: SURGICAL PELVIC ORGAN PROLAPSE/PELVIC FLOOR RECONSTRUCTION MARKET, BY TYPE, 2023–2030 (USD MILLION)
TABLE 238
CHINA: NON-SURGICAL PELVIC ORGAN PROLAPSE/PELVIC FLOOR RECONSTRUCTION MARKET, BY TYPE, 2023–2030 (USD MILLION)
TABLE 239
CHINA: PELVIC ORGAN PROLAPSE/PELVIC FLOOR RECONSTRUCTION MARKET, BY APPLICATION, 2023–2030 (USD MILLION)
TABLE 240
CHINA: PELVIC ORGAN PROLAPSE/PELVIC FLOOR RECONSTRUCTION MARKET, BY END USER, 2023–2030 (USD MILLION)
TABLE 241
JAPAN: PELVIC ORGAN PROLAPSE/PELVIC FLOOR RECONSTRUCTION MARKET, BY PRODUCT, 2023–2030 (USD MILLION)
TABLE 242
JAPAN: PELVIC ORGAN PROLAPSE/PELVIC FLOOR RECONSTRUCTION MARKET, BY TREATMENT, 2023–2030 (USD MILLION)
TABLE 243
JAPAN: SURGICAL PELVIC ORGAN PROLAPSE/PELVIC FLOOR RECONSTRUCTION MARKET, BY TYPE, 2023–2030 (USD MILLION)
TABLE 244
JAPAN: NON-SURGICAL PELVIC ORGAN PROLAPSE/PELVIC FLOOR RECONSTRUCTION MARKET, BY TYPE, 2023–2030 (USD MILLION)
TABLE 245
JAPAN: PELVIC ORGAN PROLAPSE/PELVIC FLOOR RECONSTRUCTION MARKET, BY APPLICATION, 2023–2030 (USD MILLION)
TABLE 246
JAPAN: PELVIC ORGAN PROLAPSE/PELVIC FLOOR RECONSTRUCTION MARKET, BY END USER, 2023–2030 (USD MILLION)
TABLE 247
INDIA: PELVIC ORGAN PROLAPSE/PELVIC FLOOR RECONSTRUCTION MARKET, BY PRODUCT, 2023–2030 (USD MILLION)
TABLE 248
INDIA: PELVIC ORGAN PROLAPSE/PELVIC FLOOR RECONSTRUCTION MARKET, BY TREATMENT, 2023–2030 (USD MILLION)
TABLE 249
INDIA: SURGICAL PELVIC ORGAN PROLAPSE/PELVIC FLOOR RECONSTRUCTION MARKET, BY TYPE, 2023–2030 (USD MILLION)
TABLE 250
INDIA: NON-SURGICAL PELVIC ORGAN PROLAPSE/PELVIC FLOOR RECONSTRUCTION MARKET, BY TYPE, 2023–2030 (USD MILLION)
TABLE 251
INDIA: PELVIC ORGAN PROLAPSE/PELVIC FLOOR RECONSTRUCTION MARKET, BY APPLICATION, 2023–2030 (USD MILLION)
TABLE 252
INDIA: PELVIC ORGAN PROLAPSE/PELVIC FLOOR RECONSTRUCTION MARKET, BY END USER, 2023–2030 (USD MILLION)
TABLE 253
AUSTRALIA: PELVIC ORGAN PROLAPSE/PELVIC FLOOR RECONSTRUCTION MARKET, BY PRODUCT, 2023–2030 (USD MILLION)
TABLE 254
AUSTRALIA: PELVIC ORGAN PROLAPSE/PELVIC FLOOR RECONSTRUCTION MARKET, BY TREATMENT, 2023–2030 (USD MILLION)
TABLE 255
AUSTRALIA: SURGICAL PELVIC ORGAN PROLAPSE/PELVIC FLOOR RECONSTRUCTION MARKET, BY TYPE, 2023–2030 (USD MILLION)
TABLE 256
AUSTRALIA: NON-SURGICAL PELVIC ORGAN PROLAPSE/PELVIC FLOOR RECONSTRUCTION MARKET, BY TYPE, 2023–2030 (USD MILLION)
TABLE 257
AUSTRALIA: PELVIC ORGAN PROLAPSE/PELVIC FLOOR RECONSTRUCTION MARKET, BY APPLICATION, 2023–2030 (USD MILLION)
TABLE 258
AUSTRALIA: PELVIC ORGAN PROLAPSE/PELVIC FLOOR RECONSTRUCTION MARKET, BY END USER, 2023–2030 (USD MILLION)
TABLE 259
SOUTH KOREA: PELVIC ORGAN PROLAPSE/PELVIC FLOOR RECONSTRUCTION MARKET, BY PRODUCT, 2023–2030 (USD MILLION)
TABLE 260
SOUTH KOREA: PELVIC ORGAN PROLAPSE/PELVIC FLOOR RECONSTRUCTION MARKET, BY TREATMENT, 2023–2030 (USD MILLION)
TABLE 261
SOUTH KOREA: SURGICAL PELVIC ORGAN PROLAPSE/PELVIC FLOOR RECONSTRUCTION MARKET, BY TYPE, 2023–2030 (USD MILLION)
TABLE 262
SOUTH KOREA: NON-SURGICAL PELVIC ORGAN PROLAPSE/PELVIC FLOOR RECONSTRUCTION MARKET, BY TYPE, 2023–2030 (USD MILLION)
TABLE 263
SOUTH KOREA: PELVIC ORGAN PROLAPSE/PELVIC FLOOR RECONSTRUCTION MARKET, BY APPLICATION, 2023–2030 (USD MILLION)
TABLE 264
SOUTH KOREA: PELVIC ORGAN PROLAPSE/PELVIC FLOOR RECONSTRUCTION MARKET, BY END USER, 2023–2030 (USD MILLION)
TABLE 265
REST OF ASIA PACIFIC: PELVIC ORGAN PROLAPSE/PELVIC FLOOR RECONSTRUCTION MARKET, BY PRODUCT, 2023–2030 (USD MILLION)
TABLE 266
REST OF ASIA PACIFIC: PELVIC ORGAN PROLAPSE/PELVIC FLOOR RECONSTRUCTION MARKET, BY TREATMENT, 2023–2030 (USD MILLION)
TABLE 267
REST OF ASIA PACIFIC: SURGICAL PELVIC ORGAN PROLAPSE/PELVIC FLOOR RECONSTRUCTION MARKET, BY TYPE, 2023–2030 (USD MILLION)
TABLE 268
REST OF ASIA PACIFIC: NON-SURGICAL PELVIC ORGAN PROLAPSE/PELVIC FLOOR RECONSTRUCTION MARKET, BY TYPE, 2023–2030 (USD MILLION)
TABLE 269
REST OF ASIA PACIFIC: PELVIC ORGAN PROLAPSE/PELVIC FLOOR RECONSTRUCTION MARKET, BY APPLICATION, 2023–2030 (USD MILLION)
TABLE 270
REST OF ASIA PACIFIC: PELVIC ORGAN PROLAPSE/PELVIC FLOOR RECONSTRUCTION MARKET, BY END USER, 2023–2030 (USD MILLION)
TABLE 271
LATIN AMERICA: KEY MACROECONOMIC INDICATORS
TABLE 272
LATIN AMERICA: PELVIC ORGAN PROLAPSE/PELVIC FLOOR RECONSTRUCTION MARKET, BY COUNTRY, 2023–2030 (USD MILLION)
TABLE 273
LATIN AMERICA: PELVIC ORGAN PROLAPSE/PELVIC FLOOR RECONSTRUCTION MARKET, BY PRODUCT, 2023–2030 (USD MILLION)
TABLE 274
LATIN AMERICA: PELVIC ORGAN PROLAPSE/PELVIC FLOOR RECONSTRUCTION MARKET, BY TREATMENT, 2023–2030 (USD MILLION)
TABLE 275
LATIN AMERICA: SURGICAL PELVIC ORGAN PROLAPSE/PELVIC FLOOR RECONSTRUCTION MARKET, BY TYPE, 2023–2030 (USD MILLION)
TABLE 276
LATIN AMERICA: NON-SURGICAL PELVIC ORGAN PROLAPSE/PELVIC FLOOR RECONSTRUCTION MARKET, BY TYPE, 2023–2030 (USD MILLION)
TABLE 277
LATIN AMERICA: PELVIC ORGAN PROLAPSE/PELVIC FLOOR RECONSTRUCTION MARKET, BY APPLICATION, 2023–2030 (USD MILLION)
TABLE 278
LATIN AMERICA: PELVIC ORGAN PROLAPSE/PELVIC FLOOR RECONSTRUCTION MARKET, BY END USER, 2023–2030 (USD MILLION)
TABLE 279
BRAZIL: PELVIC ORGAN PROLAPSE/PELVIC FLOOR RECONSTRUCTION MARKET, BY PRODUCT, 2023–2030 (USD MILLION)
TABLE 280
BRAZIL: PELVIC ORGAN PROLAPSE/PELVIC FLOOR RECONSTRUCTION MARKET, BY TREATMENT, 2023–2030 (USD MILLION)
TABLE 281
BRAZIL: SURGICAL PELVIC ORGAN PROLAPSE/PELVIC FLOOR RECONSTRUCTION MARKET, BY TYPE, 2023–2030 (USD MILLION)
TABLE 282
BRAZIL: NON-SURGICAL PELVIC ORGAN PROLAPSE/PELVIC FLOOR RECONSTRUCTION MARKET, BY TYPE, 2023–2030 (USD MILLION)
TABLE 283
BRAZIL: PELVIC ORGAN PROLAPSE/PELVIC FLOOR RECONSTRUCTION MARKET, BY APPLICATION, 2023–2030 (USD MILLION)
TABLE 284
BRAZIL: PELVIC ORGAN PROLAPSE/PELVIC FLOOR RECONSTRUCTION MARKET, BY END USER, 2023–2030 (USD MILLION)
TABLE 285
MEXICO: PELVIC ORGAN PROLAPSE/PELVIC FLOOR RECONSTRUCTION MARKET, BY PRODUCT, 2023–2030 (USD MILLION)
TABLE 286
MEXICO: PELVIC ORGAN PROLAPSE/PELVIC FLOOR RECONSTRUCTION MARKET, BY TREATMENT, 2023–2030 (USD MILLION)
TABLE 287
MEXICO: SURGICAL PELVIC ORGAN PROLAPSE/PELVIC FLOOR RECONSTRUCTION MARKET, BY TYPE, 2023–2030 (USD MILLION)
TABLE 288
MEXICO: NON-SURGICAL PELVIC ORGAN PROLAPSE/PELVIC FLOOR RECONSTRUCTION MARKET, BY TYPE, 2023–2030 (USD MILLION)
TABLE 289
MEXICO: PELVIC ORGAN PROLAPSE/PELVIC FLOOR RECONSTRUCTION MARKET, BY APPLICATION, 2023–2030 (USD MILLION)
TABLE 290
MEXICO: PELVIC ORGAN PROLAPSE/PELVIC FLOOR RECONSTRUCTION MARKET, BY END USER, 2023–2030 (USD MILLION)
TABLE 291
REST OF LATIN AMERICA: PELVIC ORGAN PROLAPSE/PELVIC FLOOR RECONSTRUCTION MARKET, BY PRODUCT, 2023–2030 (USD MILLION)
TABLE 292
REST OF LATIN AMERICA: PELVIC ORGAN PROLAPSE/PELVIC FLOOR RECONSTRUCTION MARKET, BY TREATMENT, 2023–2030 (USD MILLION)
TABLE 293
REST OF LATIN AMERICA: SURGICAL PELVIC ORGAN PROLAPSE/PELVIC FLOOR RECONSTRUCTION MARKET, BY TYPE, 2023–2030 (USD MILLION)
TABLE 294
REST OF LATIN AMERICA: NON-SURGICAL PELVIC ORGAN PROLAPSE/PELVIC FLOOR RECONSTRUCTION MARKET, BY TYPE, 2023–2030 (USD MILLION)
TABLE 295
REST OF LATIN AMERICA: PELVIC ORGAN PROLAPSE/PELVIC FLOOR RECONSTRUCTION MARKET, BY APPLICATION, 2023–2030 (USD MILLION)
TABLE 296
REST OF LATIN AMERICA: PELVIC ORGAN PROLAPSE/PELVIC FLOOR RECONSTRUCTION MARKET, BY END USER, 2023–2030 (USD MILLION)
TABLE 297
MIDDLE EAST & AFRICA: KEY MACROECONOMIC INDICATORS
TABLE 298
MIDDLE EAST & AFRICA: PELVIC ORGAN PROLAPSE/PELVIC FLOOR RECONSTRUCTION MARKET, BY PRODUCT, 2023–2030 (USD MILLION)
TABLE 299
MIDDLE EAST & AFRICA: PELVIC ORGAN PROLAPSE/PELVIC FLOOR RECONSTRUCTION MARKET, BY TREATMENT, 2023–2030 (USD MILLION)
TABLE 300
MIDDLE EAST & AFRICA: SURGICAL PELVIC ORGAN PROLAPSE/PELVIC FLOOR RECONSTRUCTION MARKET, BY TYPE, 2023–2030 (USD MILLION)
TABLE 301
MIDDLE EAST & AFRICA: NON-SURGICAL PELVIC ORGAN PROLAPSE/PELVIC FLOOR RECONSTRUCTION MARKET, BY TYPE, 2023–2030 (USD MILLION)
TABLE 302
MIDDLE EAST & AFRICA: PELVIC ORGAN PROLAPSE/PELVIC FLOOR RECONSTRUCTION MARKET, BY APPLICATION, 2023–2030 (USD MILLION)
TABLE 303
MIDDLE EAST & AFRICA: PELVIC ORGAN PROLAPSE/PELVIC FLOOR RECONSTRUCTION MARKET, BY END USER, 2023–2030 (USD MILLION)
TABLE 304
KEY PLAYER STRATEGIES/RIGHT TO WIN, 2022–2025
TABLE 305
PELVIC ORGAN PROLAPSE/PELVIC FLOOR RECONSTRUCTION MARKET: DEGREE OF COMPETITION
TABLE 306
REGION FOOTPRINT
TABLE 307
PRODUCT FOOTPRINT
TABLE 308
TREATMENT FOOTPRINT
TABLE 309
APPLICATION FOOTPRINT
TABLE 310
LIST OF START-UPS/SMES
TABLE 311
COMPETITIVE BENCHMARKING OF START-UPS/SMES
TABLE 312
PELVIC ORGAN PROLAPSE/PELVIC FLOOR RECONSTRUCTION MARKET: PRODUCT LAUNCHES/APPROVALS, 2022–2025
TABLE 313
PELVIC ORGAN PROLAPSE/PELVIC FLOOR RECONSTRUCTION MARKET: DEALS, 2022–2025
TABLE 314
PELVIC ORGAN PROLAPSE/PELVIC FLOOR RECONSTRUCTION MARKET: OTHER DEVELOPMENTS, 2022–2025
TABLE 315
BOSTON SCIENTIFIC CORPORATION: COMPANY OVERVIEW
TABLE 316
BOSTON SCIENTIFIC CORPORATION: PRODUCTS OFFERED
TABLE 317
BOSTON SCIENTIFIC CORPORATION: DEALS
TABLE 318
COLOPLAST GROUP: COMPANY OVERVIEW
TABLE 319
COLOPLAST GROUP: PRODUCTS OFFERED
TABLE 320
INTUITIVE SURGICAL OPERATIONS, INC.: COMPANY OVERVIEW
TABLE 321
INTUITIVE SURGICAL OPERATIONS, INC.: PRODUCTS OFFERED
TABLE 322
INTUITIVE SURGICAL OPERATIONS, INC.: PRODUCT LAUNCHES/APPROVALS
TABLE 323
COOPERCOMPANIES: COMPANY OVERVIEW
TABLE 324
COOPERCOMPANIES: PRODUCTS OFFERED
TABLE 325
COOPERCOMPANIES: DEALS
TABLE 326
JOHNSON & JOHNSON: COMPANY OVERVIEW
TABLE 327
JOHNSON & JOHNSON: PRODUCTS OFFERED
TABLE 328
JOHNSON & JOHNSON: PRODUCT LAUNCHES/APPROVALS
TABLE 329
JOHNSON & JOHNSON: DEALS
TABLE 330
JOHNSON & JOHNSON: OTHER DEVELOPMENTS
TABLE 331
GE HEALTHCARE: COMPANY OVERVIEW
TABLE 332
GE HEALTHCARE: PRODUCTS OFFERED
TABLE 333
GE HEALTHCARE: PRODUCT LAUNCHES/APPROVALS
TABLE 334
GE HEALTHCARE: DEALS
TABLE 335
GE HEALTHCARE: OTHER DEVELOPMENTS
TABLE 336
INTEGRA LIFESCIENCES CORPORATION: COMPANY OVERVIEW
TABLE 337
INTEGRA LIFESCIENCES CORPORATION: PRODUCTS OFFERED
TABLE 338
B. BRAUN SE: COMPANY OVERVIEW
TABLE 339
B. BRAUN SE: PRODUCTS OFFERED
TABLE 340
B. BRAUN SE: DEALS
TABLE 341
PFM MEDICAL GMBH: COMPANY OVERVIEW
TABLE 342
PFM MEDICAL GMBH: PRODUCTS OFFERED
TABLE 343
CALDERA MEDICAL: COMPANY OVERVIEW
TABLE 344
CALDERA MEDICAL: PRODUCTS OFFERED
TABLE 345
CALDERA MEDICAL: DEALS
FIGURE 1
PELVIC ORGAN PROLAPSE/PELVIC FLOOR RECONSTRUCTION MARKET SEGMENTATION
FIGURE 3
TOP-DOWN APPROACH
FIGURE 4
DATA TRIANGULATION
FIGURE 5
PELVIC ORGAN PROLAPSE/PELVIC FLOOR RECONSTRUCTION MARKET, BY PRODUCT, 2025 VS. 2030 (USD MILLION)
FIGURE 6
PELVIC ORGAN PROLAPSE/PELVIC FLOOR RECONSTRUCTION MARKET, BY TREATMENT, 2025 VS. 2030 (USD MILLION)
FIGURE 7
PELVIC ORGAN PROLAPSE/PELVIC FLOOR RECONSTRUCTION MARKET, BY APPLICATION, 2025 VS. 2030 (USD MILLION)
FIGURE 8
PELVIC ORGAN PROLAPSE/PELVIC FLOOR RECONSTRUCTION MARKET, BY END USER, 2025 VS. 2030 (USD MILLION)
FIGURE 9
GEOGRAPHICAL SNAPSHOT OF PELVIC ORGAN PROLAPSE/PELVIC FLOOR RECONSTRUCTION MARKET
FIGURE 10
RISE IN FEMALE GERIATRIC POPULATION TO DRIVE MARKET
FIGURE 11
HOSPITALS AND CHINA ACCOUNTED FOR SIGNIFICANT SHARES IN 2024
FIGURE 12
ASIA PACIFIC TO EXHIBIT FASTEST GROWTH DURING FORECAST PERIOD
FIGURE 13
INDIA TO BE FASTEST-GROWING MARKET DURING FORECAST PERIOD
FIGURE 14
PELVIC ORGAN PROLAPSE/PELVIC FLOOR RECONSTRUCTION MARKET DYNAMICS
FIGURE 15
TRENDS AND DISRUPTIONS IMPACTING CUSTOMER BUSINESS
FIGURE 16
VALUE CHAIN ANALYSIS
FIGURE 17
SUPPLY CHAIN ANALYSIS
FIGURE 18
ECOSYSTEM ANALYSIS
FIGURE 19
INVESTMENT AND FUNDING SCENARIO, 2020–2025 (USD MILLION)
FIGURE 20
PATENT ANALYSIS
FIGURE 21
PORTER’S FIVE FORCES ANALYSIS
FIGURE 22
INFLUENCE OF STAKEHOLDERS ON BUYING PROCESS FOR TOP FOUR PRODUCTS
FIGURE 23
KEY BUYING CRITERIA FOR TOP FOUR PRODUCTS
FIGURE 24
IMPACT OF AI ON PELVIC ORGAN PROLAPSE/PELVIC FLOOR RECONSTRUCTION MARKET
FIGURE 25
NORTH AMERICA: PELVIC ORGAN PROLAPSE/PELVIC FLOOR RECONSTRUCTION MARKET SNAPSHOT
FIGURE 26
ASIA PACIFIC: PELVIC ORGAN PROLAPSE/PELVIC FLOOR RECONSTRUCTION MARKET SNAPSHOT
FIGURE 27
REVENUE ANALYSIS OF KEY PLAYERS, 2022–2024 (USD MILLION)
FIGURE 28
MARKET SHARE ANALYSIS OF KEY PLAYERS, 2024
FIGURE 29
COMPANY EVALUATION MATRIX (KEY PLAYERS), 2024
FIGURE 30
COMPANY FOOTPRINT
FIGURE 31
COMPANY EVALUATION MATRIX (START-UPS/SMES), 2024
FIGURE 32
YEAR-TO-DATE (YTD) PRICE TOTAL RETURN AND FIVE-YEAR STOCK BETA OF KEY VENDORS
FIGURE 33
EV/EBITDA OF KEY VENDORS
FIGURE 34
BRAND/PRODUCT COMPARATIVE ANALYSIS
FIGURE 35
BOSTON SCIENTIFIC CORPORATION: COMPANY SNAPSHOT
FIGURE 36
COLOPLAST GROUP: COMPANY SNAPSHOT
FIGURE 37
INTUITIVE SURGICAL OPERATIONS, INC.: COMPANY SNAPSHOT
FIGURE 38
COOPERCOMPANIES: COMPANY SNAPSHOT
FIGURE 39
JOHNSON & JOHNSON: COMPANY SNAPSHOT
FIGURE 40
GE HEALTHCARE: COMPANY SNAPSHOT
FIGURE 41
INTEGRA LIFESCIENCES CORPORATION: COMPANY SNAPSHOT
FIGURE 42
B. BRAUN SE: COMPANY SNAPSHOT
Growth opportunities and latent adjacency in POP Treatment and Management / Pelvic Organ Prolapse Market